NCT05508906 Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer Status RECRUITING Phase PHASE1
NCT05505175 Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC Status COMPLETED Phase N/A
NCT05501769 ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Status COMPLETED Phase PHASE1
NCT05498701 A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food Status COMPLETED Phase PHASE1
NCT05496738 A Preliminary Study to Evaluate PF-07264660 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05489328 Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age Status COMPLETED Phase PHASE1
NCT05487703 A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting Status COMPLETED Phase N/A
NCT05487040 A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Status TERMINATED Phase PHASE1
NCT05482308 A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants Status COMPLETED Phase PHASE1
NCT05478603 A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver Dysfunction Status COMPLETED Phase PHASE1
NCT05478590 A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting Status COMPLETED Phase N/A
NCT05477524 An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) Status COMPLETED Phase PHASE3
NCT05472038 A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals Status COMPLETED Phase PHASE2/PHASE3
NCT05471505 Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding Status COMPLETED Phase N/A
NCT05471492 Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease Status WITHDRAWN Phase PHASE2
NCT05466578 Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842) Status AVAILABLE Phase N/A
NCT05463952 A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC) Status ACTIVE_NOT_RECRUITING Phase PHASE1